I

Inthera Bioscience AG

4 employees

Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2013

Funding rounds raised

Total raised

$11M

from 6 investors over 6 rounds

I

Inthera Bioscience AG raised $5.5M on June 26, 2018

Investors: Novo Holdings and M Ventures

I

Inthera Bioscience AG raised $11M on May 31, 2017

Investors: Novo Holdings and M Ventures

I

Inthera Bioscience AG raised $3.7M on December 14, 2015

Investors: Novo Holdings and EVA - the Basel start-up agency

FAQ